jzs-10739

Antimicrobial peptides and their therapeutic potential as anti-infective drugs: A review

Azhen Fatih Muhammad1

1 Directorate of veterinary Hospital, Sulaimani City, Kurdistan Region, Iraq

Original: 29 July 2018, Revised: 10 January 2019, Accepted: 17 February 2019, Published online: 20 June 2019

DOI Link: https://doi.org/10.17656/jzs.10739

Abstract

Antimicrobial peptides (AMPs), also referred to as host defense peptides, are small molecular weight proteins with broad spectrum antimicrobial activity against bacteria viruses, fungi, and parasites. The AMPs areimportant components of innate immune systems. They are believed to be existed more than 2.6 billion years ago as part of the innate immunity in primitive organisms. The antimicrobial activity of these natural peptidesmakes them possible candidates in the development of new drugs against the multidrug resistant bacterial strains that have emerged recently. However, development of new therapeutics from the natural source Anti-infective drugs (AMPs) seems to be faced with many problems, such as toxicity, rapid, degradation and inability to maintain required concentrations in the target tissues. This review focuses on the therapeutic possibility of thenatural antimicrobial peptides, the advantages and disadvantages of these compounds when used for topical and systemic applications, as well as their possible utilization in the development of new anti- infective drugs.

Key Words: Antimicrobial peptides, AMPs, Anti-infective

References

[1] Hancock RE, and Lehrer R. ''Cationic peptides. A new source of antibiotics''. Tends in Biotechnology, Vol. 16, pp. 82–88. (1998).

[2] Zasloff M. "Antimicrobial peptides of multicellular organisms". Nature, Vol. 415, pp. 389–395. (2002).

[3] Yeaman MR. and Yount NY. "Mechanisms of Antimicrobial Peptide Action and Resistance". Pharmacological Reviews, Vol. 55, pp. 27–55. (2003).

[4] Brogden KA. "Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?". Nature Reviews Microbiology, Vol. 3, pp. 238–250. (2005).

[5] Lai Y, and Gallo RL. "AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense". Trends in Immunology, Vol. 30, No.3, pp. 131–141. (2009).

[6] Brown KL, and Hancock RE. " Cationic host defense (antimicrobial) peptides". Current Opinion in Immunology, Vol. 18, pp. 24–30. (2006).

[7] Harris F, and Dennison SR. "Phoenix D.A. Anionic antimicrobial peptides from organisms". Current Protein and Peptide Science, Vol. 10, pp. 585–606. (2009).

[8] Groenink J, Walgreen-Weterings E, van’t HW, Veerman EC, Nieuw AV. "Cationic amphipathic peptides, derived from bovine and human lactoferrins with antimicrobial activity against oral pathogens". Microbiology Letters, FEMS, Vol. 179, pp. 217–222. (1999).

[9] Bradshaw J. "Cationic antimicrobial peptides: Issues for potential clinical use". BioDrugs, Vol. 17, pp. 233–240. (2003).

[10] Riedl S, Zweytick D, and Lohner K. "Membrane-active host defense peptides- challenges and perspectives for the development of novel anticancer drugs". Chemistry and Physics of Lipids, Vol. 164, pp. 766–781. (2011).

[11] Huang YB, Huang JF, and Chen YX. "Alpha-helical cationic antimicrobial peptides: Relationships of structure and function". Protein and Cell, Vol. 1, No. 2, pp. 143–152. (2010).

[12] Dubos RJ. "Studies on a bactericidal agent extracted from a soil bacillus: I Preparation of the agent. Its activity in vitro". Journal of Experimental Medicine, Vol. 70, pp. 1–10. (1939).

[13] Hotchkiss RD, and Dubos RJ. "Fractionation of the bactericidal agent from cultures of a soil Bacillus". Journal of Biological Chemistry, Vol. 132, pp.791–79152. (1940).

[14] Van Epps HL, and Dubos R. "Unearthing antibiotics". Journal of Experimental Medicine Vol. 203, pp. 259. (2006).

[15] Dubos RJ, and Hotchkiss RD. "The production of bactericidal substances by aerobic sporulating bacilli". Journal of Experimental Medicine, Vol. 73, pp. 629–640. (1941).

[16] Balls AK. "A crystalline protein obtained from a lipoprotein of wheat flour". Cereal Chemistry , Vol. 19, pp. 279–288. (1942).

[17] Ohtani S, Okada T, Yoshizumi H, and Kagamiyama H. "Complete primary structures of two subunits of purothionin a, a lethal protein for brewer’s yeast from wheat flour". Journal of Biochemistry, Vol. 82, pp. 753–76. (1977).

[18] GordonYJ, Romanowski EG, and McDermott AM. "A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs". Current Eye Research,Vol. 30, No. 7, pp. 505–515. (2006).

[19] Winder PL, Pomponi SA, and Wright AE. "Natural Products from the Lithistid Review of the Literature since". Marine Drugs, Vol. 9, pp. 2643–2682. (2000).

[20] Mayer AM, Rodriguez AD, Berlinck RG, and Fusetani N. "Marine pharmacology in 2007–2008: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis and antiviral activities; affecting the immune and nervous system and other miscellaneous mechanism of action". Comparative Biochemistry andPhysiology Part- C: Toxicology and Pharmacology,Vol. 153, pp.191–222. ( 2011).

[22] Mayer AM, Rodríguez AD, Taglialatela-Scafati O. Fusetani N. "Marine pharmacology in 2009-2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action". Marine Drugs, Vol.11, No. 7, pp. 2510–2573. (2013).

[23] Verhoef J. "Antibiotic resistance: the pandemic". Advances in Experimental Medicine and Biology, Vol. 531, pp. 301– 313. (2003).

[24] Walsh CT, and Wencewicz TA. "Prospects for new antibiotics: a molecule-centered perspective". The Journal of Antibiotics, Vol. 67, No. 1, pp. 7-22. (2014).

[25] Hawkins, and Jabari "Application of Antimicrobial Agents via Commercial Spray Cabinet to Inactivate Salmonella on Skinless Chicken Meat". Annual Meeting. (2015).

[26] Grünewald J, and Marahiel MA. "Chemoenzymatic and templatedirected synthesis of bioactive macrocyclic peptides". Microbiology and Molecular Biology Reviews,Vol. 70, pp. 121–146. (2006).

[27] Zavascki AP, Goldani LZ, Li J, and Nation RL. "Polymyxin B for the treatment of multidrug-resistant pathogens:A critical review". Journal of Antimicrbial Chemotherapy,Vol.60,  pp. 1206–1215.  (2007).

[28] Economou NJ, Cocklin S, and Loll PJ. "Highresolution crystal structure reveals molecular details of target recognition by bacitracin".  Proceedings of Natural Academy of Sciences ofUSA,Vol. 110, pp. 14207–14212. (2013).

[29] Hofmann CM, Anderson JM, and Marchant RE. "Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen- derived peptide". Journal of Biomedical Materials Research Part A,Vol. 100, pp. 2517–2525. (2012).

[30] Epand RM, and Vogel HJ. "Diversity of antimicrobial peptides and their mechanisms of action". Biochimica et Biophysica Acta, Vol. 1462, pp. 11–28. (1999).

[31] Cole AM, Shi J, Ceccarelli A, Kim YH, Park A, and Ganz T. "Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance bacteria from wounds". Blood,Vol. 97, pp. 297–304. (2001).

[32] Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, and Gudmundsson G. "Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator". Natural Medicine, Vol. 7, pp. 180–185. (2001).

[33] Bals R, Weiner D, Meegalla R, and Wilson J. "Transfer of a cathelicidin peptid antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model". Journal of Clinical Investigations,Vol. 103, pp. 1113–1117. (1999).

[34] Mor A, and Pierre N. "Isolation and structure of novel defensive peptides from frog skin". European Journal of Biochemistry,Vol. 219, No. 1-2, pp.145-154. (1994).

[35] Samakovlis C, Kylsten P, Kimbrell DA, Engstroëm A, and Hultmark D. "The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster". The EMBO Journal, Vol.10, No. 1, pp. 163-169. (1991).

[36] Chernysh Sergey K, Bekkers PG, Filatova VA, and Anikin N, Platonov V, Bullet V, and Philippe. "Antiviral and antitumor peptides from insects". Proceedings of the National Academy of Sciences, Vol. 99, No. 20, pp. 12628-12632. (2002).

[37] Bellamy W, Takase M, Wakabayashi H, Kawase K, and Tomita M. "Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin". Journal of Applied Bacteriology, Vol. 73, No. 6, pp. 472-479. (1992).

[38] Lamberty M, Caille A, Landon C, Tassin-Moindrot S, Hetru C, Bullet P, and Vovelle F. "Solution structures of the antifungal heliomicina selected variant with both antibacterial and antifungal activities". Biochemistry. Vol. 40, No. 40, pp. 11995-12003. (2001).

[39] Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, and Tyler MJ. "The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria Aurea and Litoriaraniformi". European Journal of Biochemistry, Vol. 267, No. 17, pp. 5330-5341. (2000).

[40] Simmaco MM, Giuseppina C, Silvia M, Rossella M, Maria LB, and Donatella T. "Antimicrobial peptides from the European red frog Rana temporaria". European Journal of Biochemistry, Vol. 242, No. 3, pp. 788-792. (1996).

[41] Zasloff M. "Magainins, a class of antimicrobial peptides from Xenopus skin: solation, characterization of two active forms, and partial cDNA sequence of a precursor". Proceedings of the National Academy of Sciences, Vol. 84, No. 15, pp. 5449-5453. (1987).

[42] Aderem A, and Ulevitch R. " Toll-like receptors in the induction of the innate immune response" Nature, Vol. 406, No. 6797, pp. 782-787. (2000).

[43] Hancock RE, and Lehrer R. "Cationic peptides: A new source of antibiotics". Trends in Biotechnology, Vol. 16, pp. 82–88. (1998).

[44] Brogden KA, Mark M, Paul BT, and Brian F. "Juruin: an antifungal peptide from the venom of the Amazonian Pink Toe spider, Avicularia juruensis, which contains the inhibitory cystine knot motif ". Frontiers in Microbiology, Vol. 10, pp. 139. (2014).

[45] Hof WV, Enno C, Eva J, and Arie V. "Antimicrobial peptides properties and applicability". Biological Chemistry, Vol. 38, No.4, pp. 597-619. (2001).

[46] Koczulla B, and Robert A. "Antimicrobial peptides". Drugs,Vol. 63, No.4, pp. 389-406. (2003).

[47] Huang L, Proske R, and McDermott A. "Functional Roles of the Epithelial– Derived Antimicrobial Peptide LL–37 at the Ocular Surface". Investigative Ophthalmology & Visual Science, Vol. 45, PP. 4940-4940. (2004).

[48] Shea and Katherine M. "Antibiotic resistance: What is the impact of agricultural uses of antibiotics on children’s health?". Pediatrics, Vol. 112, No. 1, pp. 253-258. (2003).

[49] Andres       E, and Dimarco J. "Cationic antimicrobial peptides: update of clinical development". Journal of Internal Medicine, Vol. 255, No. 4 , pp. 519-520. (2004).

[50] Matsuzaki K. "Magainins as paradigm for the mode of action of pore forming polypeptides". Biochimica Biophysica Acta (BBA)-Reviews on Biomembranes, Vol. 1376, No. 3, pp. 391-400. (1998).

[51] Mather R, Karenchak L, Romanowski E, and Kowalski R. "Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics". American journal of Ophthalmology, Vol. 133, No. 4, pp. 463-466. (2002).

[52] Kowalski R, Dhaliwal D, Karenchak L, Romanowski E, Mah F, Ritterband D, and Gordon Y. "Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin ciprofloxacin, and ofloxacin using bacterial keratitis isolates". American Journal of phthalmology, Vol. 136, No. 3, pp. 500-505. (2003).

[53] Patch JA,and Barron AE. "Helical peptoid mimics of magainin-2 amide". Journal of the American Chemical Society, Vol. 125, No. 40, pp. 12092-1293.(2003).

[54] Steiner H, Hultmark D, Engstrom A, Bennich H, and Barman H. "Sequence and specicity of two antibacterial proteins involved in insect immunity". Nature,Vol. 292, pp. 246-248. (1981).

[55] Morikawa N, Hagiwara K, and Nakajima T. " Brevinin-1 and-2, unique antimicrobial peptides from the skin of the frog, Rana-brevipodaporsa". Biochemical and Biophysical Research Communications, Vol. 189 No. 1, pp. 184-190. (1992).

[56] Helynck G, Dubertret C, Mayaux J, and Leboul J. "Isolation of RP 71955, A new anti-HIV-1 peptide secondary metabolite". The Journal of Antibiotics, Vol. 46, No. 11, pp. 1756-1757. (1993).

[57] Bellamy W, Takase M, Wakabayashi H, Kawase K, and Tomita M. " Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin". Journal of Applied Bacteriology, Vol. 73, No. 6, pp. 472-479. (1992).

[58] Wong H, Bowie J, and Carver J. " The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria Splendida". European Journal of Biochemistry,Vol. 247 No. 2, pp. 545-557. (1997).

[59] Steinborner S, Currie G, Bowie J, Wallace J, and Tyler M. "New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria Chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria". The Journal of Peptide Research,Vol. 51 No. 2, pp. 121-126. (1998).

[60] Selsted M, Harwig S, Ganz T, Schilling J, and Lehrer R. "Primary structures of three human neutrophil defensins". Journal of Clinical Investigation,Vol. 76, No. 4, pp.1436. (1985).

[61] Gennaro R, Skerlavaj B, and Romeo D. "Purification, composition, and activity of two bacteriocins, antibacterial peptides of bovine neutrophils". Infection and Immunity, Vol. 57, No. 10, pp. 3142-3146 . (1989).

[62] Samakovlis C, Kylsten P, Kimbrell D, Engstroëm A, and Hultmark D. "The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster". The EMBO Journal, Vol. 10, No. 1, pp. 163-169. (1991).

[63] Mannis and Mark J. "The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis". Transactions of the American Ophthalmological Society. Vol. 100, pp. 243-271. (2002).

[64] Maisetta BG, Esin G, Luperini S, Pardini F, Bottai M, Florio D, Giuca W, Gabriele M, and Mario C."Activity of human β-defensin 3 alone or combined with other antimicrobial agents against oral bacteria". Antimicrobial Agents and Chemotherapy. Vol. 47, No. 10, pp. 3349-3351. (2003).

[65] Daher KA, Michael E, and Robert I. "Direct inactivation of viruses by human granulocyte defensins". Journal of Virology, Vol. 60, No. 3, pp. 1068-1074. (1986).

[66] McDermott A, Rich D, Cullor J, Mannis M, Smith W, Reid T, and Murphy C. "The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears". British Journal of Ophthalmology, Vol. 90, No. 5, pp. 609-611. (2006).

[67] McDermott A. "The role of antimicrobial peptides at the ocular surface". Ophthalmic Research,Vol. 41, No. 2, pp. 60-75. (2009).

Full Text

            Copyright (c) 2019  : Azhen Fatih Muhammad

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.